Fast reading:
- Fears concerning the risks created by uncontrolled development of AI are understandable, however, they should not obscure the huge societal benefits the technology can offer. The health sector is one area where we see clear potential for AI to deliver positive impact.
- Digitally driven drug discovery will benefit society by unlocking solutions to the most intractable problems in pharmaceutical research. Using the power of AI and big data in this way also holds the promise of reducing the cost of drugs, thereby increasing access for all.
- Plus: Find out how portfolio holding AbCellera, a Canadian biotechnology company focused on accelerating antibody discovery, partners with drug developers to push therapeutic programmes forward and fight disease.
To find out more about the Impact Opportunities Equity strategy, please explore our capability page.
Impact Opportunities, Q2 2023
Archive: Previous editions
Please see previous editions of our Impact Opportunities reporting below:
Share:
